Ulcerative Colitis | CHOP Research Institute
 

Ulcerative Colitis

Published on
Aug 14, 2023
By studying lab-grown organoids derived from patients’ stem cells, the Hamilton Lab seeks to better understand and treat IBD.

Dr. Mattei is an attending physician in the Division of General, Thoracic and Fetal Surgery and specializes in pediatric surgical oncology, inflammatory bowel disease, and minimally invasive and robotic surgery. His research interests are in oncology and IBD.

E-mail:
mattei [at] chop.edu

The purpose of this research study is to help us understand how well tofacitinib works as a treatment for ulcerative colitis or indeterminate colitis in pediatric patients.

Announcing a new diet trial for patients with an established diagnosis of UC.

Dr. Cardinale's research is focused on understanding the mechanisms of gene expression and gene regulation in autoimmune diseases, including inflammatory bowel disease, type 1 diabetes, and systemic sclerosis. He uses data from large-scale genomic studies to identify disease-causing genetic variants and functionally explore the target genes of those variants.

E-mail:
cardinalec [at] chop.edu
Published on
May 18, 2018
This week in the news, research from the Cardiac Center and the Division of Urology make headlines for children's health.
Published on
Jul 5, 2016
Microbes are on us and in us, and researchers are increasingly becoming aware that they are a vital part of us. Across The Children's Hospital of Philadelphia and University of Pennsylvania a variety of research efforts are underway to understand these populations of bacteria, viruses, and other tiny life forms, known as the microbiome, and their impact on health.